Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-042191
Filing Date
2024-09-27
Accepted
2024-09-27 16:17:34
Documents
23
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20034373x2_def14a.htm   iXBRL DEF 14A 1904664
6 GRAPHIC logo_tilraybrandsx1.jpg GRAPHIC 63282
7 GRAPHIC logo_tilraybrands.jpg GRAPHIC 74544
8 GRAPHIC ny20034373x2_pc01.jpg GRAPHIC 607125
9 GRAPHIC ny20034373x2_pc02.jpg GRAPHIC 482941
10 GRAPHIC ny20034373x2_pvp01.jpg GRAPHIC 175685
11 GRAPHIC ny20034373x2_pvp02.jpg GRAPHIC 174981
12 GRAPHIC ny20034373x2_pvp03.jpg GRAPHIC 166490
  Complete submission text file 0001140361-24-042191.txt   7851929

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA tlry-20241121.xsd EX-101.SCH 6356
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE tlry-20241121_def.xml EX-101.DEF 7944
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE tlry-20241121_lab.xml EX-101.LAB 14648
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE tlry-20241121_pre.xml EX-101.PRE 10448
25 EXTRACTED XBRL INSTANCE DOCUMENT ny20034373x2_def14a_htm.xml XML 512094
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 001-38594 | Film No.: 241335105
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)